Skip to main content

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Search

1062 result(s) found, displaying 351 to 375
  • Australian Public Assessment Report for Idebenone
  • Australian Public Assessment Report for Progesterone
  • Australian Public Assessment Report for Romosozumab
  • Australian Public Assessment Report for Nivolumab
  • Australian Public Assessment Report for Risankizumab
  • Australian Public Assessment Report for Lacosamide
  • Australian Public Assessment Report for Fremanezumab
  • Australian Public Assessment Report for Siponimod
  • Australian Public Assessment Report for Alirocumab (rch)
  • Australian Public Assessment Report for Polatuzumab vedotin
  • Australian Public Assessment Report for Artemether
  • Australian Public Assessment Report for Dolutegravir/Lamivudine
  • Australian Public Assessment Report for Nitric oxide
  • Australian Public Assessment Report for Odomzo
  • Australian Public Assessment Report for Cenegermin (rbe)
  • Australian Public Assessment Report for Daptomycin
  • Australian Public Assessment Report for Stiripentol
  • Australian Public Assessment Report for Ravulizumab
  • Australian Public Assessment Report for Methoxsalen

Help us improve the Therapeutic Goods Administration site